KENNEDY CAPITAL MANAGEMENT LLC - SCPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,613,420
-30.1%
226,6040.0%0.04%
-27.8%
Q2 2023$2,309,095
+12.3%
226,6040.0%0.05%
-10.0%
Q1 2023$2,055,298
+26.5%
226,6040.0%0.06%
+30.4%
Q4 2022$1,624,751226,6040.05%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,831,474$20,268,0006.83%
AIGH Capital Management LLC 637,322$3,372,0001.37%
Worth Venture Partners, LLC 162,875$862,0000.68%
Ikarian Capital, LLC 1,466,147$7,756,0000.34%
RA Capital Management 3,518,998$18,615,0000.26%
Orbimed Advisors 4,797,148$25,377,0000.22%
DAFNA Capital Management LLC 38,891$206,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 150,699$797,0000.03%
Alyeska Investment Group, L.P. 355,690$1,882,0000.03%
ALGERT GLOBAL LLC 13,860$73,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders